Dasatinib induces gene expression of CYP1A1, CYP1B1, and cardiac hypertrophy markers (BNP, β-MHC) in rat cardiomyocyte H9c2 cells

References

• Aboutabl ME, Zordoky BN, El-Kadi AO. 2009. 3-Methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats. Br J Pharmacol. 158:1808–1819.
   PubMed Web of Science ®Google Scholar
• Alsaad AM, Zordoky BN, El-Sherbeni AA, El-Kadi AO. 2012. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats. Drug Metab Dispos. 40:2126–2135.
   PubMed Web of Science ®Google Scholar
• Alsaad AM, Zordoky BN, Tse MM, El-Kadi AO. 2013. Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. Drug Metab Rev. 45:173–195.
   PubMed Web of Science ®Google Scholar
• Ansari MA, Maayah ZH, Bakheet SA, El-Kadi AO, Korashy HM. 2013. The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model. Toxicology. 306:40–49.
   PubMed Web of Science ®Google Scholar
• Beedanagari SR, Bebenek I, Bui P, Hankinson O. 2009. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicol Sci. 110:61–67.
   PubMed Web of Science ®Google Scholar
• Bieche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I. 2007. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genom. 17:731–742.
   PubMed Web of Science ®Google Scholar
• Cao Z, Li Y. 2004. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol. 489:39–48.
   PubMed Web of Science ®Google Scholar
• Chábová VČ, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Kujal P, Vernerová Z, Vaňourková Z, Kopkan L, Kramer HJ, Falck JR, et al. 2010. Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats. Clin Sci. Sci118:617–632. eng.
   PubMed Web of Science ®Google Scholar
• Chahin A, Peiffer J, Olry JC, Crepeaux G, Schroeder H, Rychen G, Guiavarc’h Y. 2013. EROD activity induction in peripheral blood lymphocytes, liver and brain tissues of rats orally exposed to polycyclic aromatic hydrocarbons. Food Chem Toxicol. 56:371–380.
   PubMed Web of Science ®Google Scholar
• Damrongwatanasuk R, Fradley MG. 2017. Cardiovascular complications of targeted therapies for chronic myeloid leukemia. Curr Treat Options Cardio Med. 19:24.
   PubMedGoogle Scholar
• Delescluse C, Lemaire G, de Sousa G, Rahmani R. 2000. Is CYP1A1 induction always related to AHR signaling pathway? Toxicology. 153:73–82.
   PubMed Web of Science ®Google Scholar
• Denison MS, Vella LM, Okey AB. 1986. Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Species difference in molecular properties of the receptors from mouse and rat hepatic cytosols. J Biol Chem. 261:3987–3995.
   PubMed Web of Science ®Google Scholar
• Dolinsky VW, Chan AY, Robillard Frayne I, Light PE, Des Rosiers C, Dyck JR. 2009. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation. 119:1643–1652.
   PubMed Web of Science ®Google Scholar
• Dubey RK, Jackson EK, Gillespie DG, Rosselli M, Barchiesi F, Krust A, Keller H, Zacharia LC, Imthurn B. 2005. Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast. J Clin Endocrinol Metab. 90:247–255.
   PubMed Web of Science ®Google Scholar
• Elbekai RH, El-Kadi AO. 2006. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther. 112:564–587.
   PubMed Web of Science ®Google Scholar
• Freebern W, Fang H, Slade M, Wells S, Canale J, Megill J, Grubor B, Fletcher A, Lee F, aS V. 2007. Dasatinib, a multi-targeted tyrosine kinase inhibitor with a different selectivity profile than imatinib, does not display cardiotoxicological potential in neonatal rat cardiomyocytes. FASEB J. 21:LB13–LB13.
   Google Scholar
• Gharavi N, El-Kadi AO. 2005. tert-Butylhydroquinone is a novel aryl hydrocarbon receptor ligand. Drug Metab Dispos. 33:365–372.
   PubMed Web of Science ®Google Scholar
• Hahn VS, Lenihan DJ, Ky B. 2014. Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies. J Am Heart Assoc. 3:e000665.
   PubMed Web of Science ®Google Scholar
• Hochhaus A, Baccarani M, Deininger M, Apperley JF, Lipton JH, Goldberg SL, Corm S, Shah NP, Cervantes F, Silver RT, et al. 2008. Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia. 22:1200–1206.
   PubMed Web of Science ®Google Scholar
• Hoegberg P, Schmidt CK, Nau H, Ross AC, Zolfaghari R, Fletcher N, Trossvik C, Nilsson CB, Hakansson H. 2003. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces lecithin: retinol acyltransferase transcription in the rat kidney. Chem Biol Interact. 145:1–16.
   PubMed Web of Science ®Google Scholar
• Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD. 2002. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension. 39:690–694.
   PubMed Web of Science ®Google Scholar
• Kimes BW, Brandt BL. 1976. Properties of a clonal muscle cell line from rat heart. Exp Cell Res. 98:367–381.
   PubMed Web of Science ®Google Scholar
• Korashy HM, El-Kadi AO. 2006. The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug Metab Rev. 38:411–450.
   PubMed Web of Science ®Google Scholar
• Korashy HM, Maayah ZH, Abd-Allah AR, El-Kadi AO, Alhaider AA. 2012. Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism. J Biomed Biotechnol. 2012:593195.
   PubMedGoogle Scholar
• Krause DS, van Etten RA. 2005. Tyrosine kinases as targets for cancer therapy. N Engl J Med. 353:172–187.
   PubMed Web of Science ®Google Scholar
• Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell. 141:1117–1134.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 25:402–408.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem. 279:23847–23850.
   PubMed Web of Science ®Google Scholar
• Roman RJ. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function [Research Support, U.S. Govt, P.H.S. Review]. Physiol Rev. 82:131–185.
   PubMed Web of Science ®Google Scholar
• Seidel SD, Li V, Winter GM, Rogers WJ, Martinez EI, Denison MS. 2000. Ah receptor-based chemical screening bioassays: application and limitations for the detection of Ah receptor agonists. Toxicol Sci. 55:107–115.
   PubMed Web of Science ®Google Scholar
• Shimada T, Fujii-Kuriyama Y. 2004. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 95:1–6.
   PubMed Web of Science ®Google Scholar
• Shimada T, Sugie A, Shindo M, Nakajima T, Azuma E, Hashimoto M, Inoue K. 2003. Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol Appl Pharmacol.187:1–10.
   PubMed Web of Science ®Google Scholar
• Thum T, Borlak J. 2000. Gene expression in distinct regions of the heart. Lancet. 355:979–983.
   PubMed Web of Science ®Google Scholar
• Thum T, Borlak J. 2002. Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB J. 16:1537–1549.
   PubMed Web of Science ®Google Scholar
• Walisser JA, Glover E, Pande K, Liss AL, Bradfield CA. 2005. Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc Natl Acad Sci USA. 102:17858–17863.
   PubMed Web of Science ®Google Scholar
• Watkins SJ, Borthwick GM, Arthur HM. 2011. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim. 47:125–131.
   PubMed Web of Science ®Google Scholar
• Whitelaw ML, Gustafsson JA, Poellinger L. 1994. Identification of transactivation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt: inducible versus constitutive modes of regulation. Mol Cell Biol. 14:8343–8355.
   PubMed Web of Science ®Google Scholar
• Ye M, Zhang Y, Gao H, Xu Y, Jing P, Wu J, Zhang X, Xiong J, Dong C, Yao L, et al. 2018. Activation of the aryl hydrocarbon receptor leads to resistance to EGFR TKIs in non-small cell lung cancer by activating Src-mediated bypass signaling. Clin Cancer Res. 24:1227–1239.
   PubMed Web of Science ®Google Scholar
• Yoshioka H, Hiromori Y, Aoki A, Kimura T, Fujii-Kuriyama Y, Nagase H, Nakanishi T. 2012. Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells. Toxicol Lett. 211:257–265.
   PubMed Web of Science ®Google Scholar
• Zordoky BN, Aboutabl ME, El-Kadi AO. 2008. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metab Dispos. 36:2277–2286.
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. 2008. Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells. Vascul Pharmacol. 49:166–172.
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. 2009. Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab. 10:164–178.
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. 2010a. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism. Toxicol In Vitro. 24:863–871.
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. 2010b. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Therap.125:446–463.
   PubMed Web of Science ®Google Scholar